Multiple sclerosis (MS) affects approximately 400,000 individuals in the United States and 2.5 million people worldwide. It is a progressive and debilitating disease that is characterized by periods of remission and relapse. Available medications can extend periods between disease flares but cannot reverse the disease process.
Treatment of MS must be individualized, but often involves the use of specialty medications that are associated with considerable costs. Common sequelae associated with MS also contribute substantially to the disease burden and costs of caring for affected patients. Adherence to medications is suboptimal due to issues including perceived lack of efficacy and adverse events.
Programs designed to support adherence can help patients develop realistic expectations, manage adverse events, improve patient quality of life, and reduce overall costs.
In this webinar, experts will discuss current and emerging treatment options for MS, and explore how value-based reimbursement models are increasingly being used by managed care organizations to tailor treatment interventions to individual patients and improve patient satisfaction with therapy.